CVE Database
/

CVE-2026-21997

Back to search

CVE-2026-21997

Published: Apr 21, 2026

Modified: Apr 22, 2026

PUBLISHED

CVSS v3.1

8.5

HIGH

Description

Vulnerability in the Oracle Life Sciences Empirica Signal product of Oracle Life Science Applications (component: Common Core). Supported versions that are affected are 9.2.1-9.2.3. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal. While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data. CVSS 3.1 Base Score 8.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N).

VendorProductVersions

Oracle Corporation

Oracle Life Sciences Empirica Signal

affected
9.2.1 - <= 9.2.3

CVSS v3.1 Details

CVSS v3.1 Vector

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N

Attack Vector

Network

Attack Complexity

Low

Privileges Required

Low

User Interaction

None

Scope

Changed

Confidentiality

Low

Integrity

High

Availability

None

References

Oracle Advisory
vendor-advisory

Security Training

Train your team to recognize and prevent security threats with our comprehensive security awareness program.

Start Training

Vulnerability Scanning

Discover vulnerabilities in your applications and infrastructure before attackers do.

Scan Now